CN108576623A - A kind of lotus seeds nut health care noodles and preparation method thereof - Google Patents
A kind of lotus seeds nut health care noodles and preparation method thereof Download PDFInfo
- Publication number
- CN108576623A CN108576623A CN201810245261.8A CN201810245261A CN108576623A CN 108576623 A CN108576623 A CN 108576623A CN 201810245261 A CN201810245261 A CN 201810245261A CN 108576623 A CN108576623 A CN 108576623A
- Authority
- CN
- China
- Prior art keywords
- parts
- nut
- lotus seeds
- health care
- noodles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 240000002853 Nelumbo nucifera Species 0.000 title claims abstract description 65
- 235000006508 Nelumbo nucifera Nutrition 0.000 title claims abstract description 65
- 235000006510 Nelumbo pentapetala Nutrition 0.000 title claims abstract description 65
- 235000012149 noodles Nutrition 0.000 title claims abstract description 43
- 230000036541 health Effects 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 239000000843 powder Substances 0.000 claims abstract description 48
- 244000062793 Sorghum vulgare Species 0.000 claims abstract description 32
- 235000019713 millet Nutrition 0.000 claims abstract description 32
- 239000002131 composite material Substances 0.000 claims abstract description 30
- 235000008216 herbs Nutrition 0.000 claims abstract description 22
- 239000000284 extract Substances 0.000 claims abstract description 20
- 235000013312 flour Nutrition 0.000 claims abstract description 17
- 235000005911 diet Nutrition 0.000 claims abstract description 15
- 230000000378 dietary effect Effects 0.000 claims abstract description 15
- 108010068370 Glutens Proteins 0.000 claims abstract description 14
- 229920002907 Guar gum Polymers 0.000 claims abstract description 14
- 239000003513 alkali Substances 0.000 claims abstract description 14
- 235000010417 guar gum Nutrition 0.000 claims abstract description 14
- 239000000665 guar gum Substances 0.000 claims abstract description 14
- 229960002154 guar gum Drugs 0.000 claims abstract description 14
- 229920001285 xanthan gum Polymers 0.000 claims abstract description 14
- 235000021312 gluten Nutrition 0.000 claims abstract description 13
- 229940100445 wheat starch Drugs 0.000 claims abstract description 5
- 235000014571 nuts Nutrition 0.000 claims description 61
- 239000000203 mixture Substances 0.000 claims description 17
- 239000002994 raw material Substances 0.000 claims description 16
- 235000017060 Arachis glabrata Nutrition 0.000 claims description 15
- 244000105624 Arachis hypogaea Species 0.000 claims description 15
- 235000010777 Arachis hypogaea Nutrition 0.000 claims description 15
- 235000018262 Arachis monticola Nutrition 0.000 claims description 15
- 235000020232 peanut Nutrition 0.000 claims description 15
- 240000007594 Oryza sativa Species 0.000 claims description 13
- 235000007164 Oryza sativa Nutrition 0.000 claims description 13
- 235000009566 rice Nutrition 0.000 claims description 13
- 235000009496 Juglans regia Nutrition 0.000 claims description 12
- 235000003434 Sesamum indicum Nutrition 0.000 claims description 12
- 241000209140 Triticum Species 0.000 claims description 12
- 235000021307 Triticum Nutrition 0.000 claims description 12
- 235000020234 walnut Nutrition 0.000 claims description 12
- 239000004615 ingredient Substances 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- 229920002472 Starch Polymers 0.000 claims description 10
- 235000019698 starch Nutrition 0.000 claims description 10
- 239000008107 starch Substances 0.000 claims description 10
- 240000007087 Apium graveolens Species 0.000 claims description 9
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 claims description 9
- 235000010591 Appio Nutrition 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 241000405414 Rehmannia Species 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 239000000047 product Substances 0.000 claims description 4
- 244000000231 Sesamum indicum Species 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 238000005096 rolling process Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 2
- 239000012982 microporous membrane Substances 0.000 claims description 2
- 240000007049 Juglans regia Species 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 235000019441 ethanol Nutrition 0.000 claims 1
- 240000004308 marijuana Species 0.000 claims 1
- 238000004806 packaging method and process Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 20
- 208000024827 Alzheimer disease Diseases 0.000 abstract description 16
- 206010039966 Senile dementia Diseases 0.000 abstract description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 230000015654 memory Effects 0.000 abstract description 7
- 235000016709 nutrition Nutrition 0.000 abstract description 6
- 210000004958 brain cell Anatomy 0.000 abstract description 5
- 230000001537 neural effect Effects 0.000 abstract description 5
- 230000035764 nutrition Effects 0.000 abstract description 5
- 150000001413 amino acids Chemical class 0.000 abstract description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 4
- 239000011707 mineral Substances 0.000 abstract description 4
- 230000032677 cell aging Effects 0.000 abstract description 3
- 230000001934 delay Effects 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 3
- 239000011782 vitamin Substances 0.000 abstract description 3
- 235000013343 vitamin Nutrition 0.000 abstract description 3
- 229930003231 vitamin Natural products 0.000 abstract description 3
- 229940088594 vitamin Drugs 0.000 abstract description 3
- 150000003722 vitamin derivatives Chemical class 0.000 abstract description 3
- 230000003078 antioxidant effect Effects 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 241000758789 Juglans Species 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 241000207961 Sesamum Species 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 102000003914 Cholinesterases Human genes 0.000 description 6
- 108090000322 Cholinesterases Proteins 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 6
- 229940048961 cholinesterase Drugs 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 210000002569 neuron Anatomy 0.000 description 6
- 241000218236 Cannabis Species 0.000 description 5
- 210000005013 brain tissue Anatomy 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 4
- 206010012289 Dementia Diseases 0.000 description 3
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- 208000037259 Amyloid Plaque Diseases 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 208000026139 Memory disease Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- GZCGUPFRVQAUEE-KCDKBNATSA-N aldehydo-D-galactose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-KCDKBNATSA-N 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- 230000001713 cholinergic effect Effects 0.000 description 2
- 230000019771 cognition Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000010172 mouse model Methods 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 235000010288 sodium nitrite Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 102100027831 14-3-3 protein theta Human genes 0.000 description 1
- CFWRDBDJAOHXSH-SECBINFHSA-N 2-azaniumylethyl [(2r)-2,3-diacetyloxypropyl] phosphate Chemical compound CC(=O)OC[C@@H](OC(C)=O)COP(O)(=O)OCCN CFWRDBDJAOHXSH-SECBINFHSA-N 0.000 description 1
- 101150079978 AGRN gene Proteins 0.000 description 1
- 102100033639 Acetylcholinesterase Human genes 0.000 description 1
- 108010022752 Acetylcholinesterase Proteins 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 208000006888 Agnosia Diseases 0.000 description 1
- 241001047040 Agnosia Species 0.000 description 1
- 108700019743 Agrin Proteins 0.000 description 1
- 102100040026 Agrin Human genes 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013455 Amyloid beta-Peptides Human genes 0.000 description 1
- 108010090849 Amyloid beta-Peptides Proteins 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 108090000189 Neuropeptides Proteins 0.000 description 1
- 102000003797 Neuropeptides Human genes 0.000 description 1
- 206010034719 Personality change Diseases 0.000 description 1
- 240000005498 Setaria italica Species 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- FRYDSOYOHWGSMD-UHFFFAOYSA-N [C].O Chemical compound [C].O FRYDSOYOHWGSMD-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 229940022698 acetylcholinesterase Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000001004 anti-acetylcholinic effect Effects 0.000 description 1
- 230000003556 anti-epileptic effect Effects 0.000 description 1
- 230000000561 anti-psychotic effect Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- -1 antidepression Substances 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 210000002932 cholinergic neuron Anatomy 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000008358 core component Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 210000001320 hippocampus Anatomy 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000007087 memory ability Effects 0.000 description 1
- 230000006386 memory function Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003061 neural cell Anatomy 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000000626 neurodegenerative effect Effects 0.000 description 1
- 210000002682 neurofibrillary tangle Anatomy 0.000 description 1
- 210000004498 neuroglial cell Anatomy 0.000 description 1
- 239000004090 neuroprotective agent Substances 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 235000002252 panizo Nutrition 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000002186 septum of brain Anatomy 0.000 description 1
- 230000036301 sexual development Effects 0.000 description 1
- 230000006403 short-term memory Effects 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/109—Types of pasta, e.g. macaroni or noodles
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/10—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by heating materials in packages which are not progressively transported through the apparatus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention belongs to field of health care food, a kind of lotus seeds nut health care noodles and preparation method thereof are disclosed, which is made of following parts by weight:15 20 parts of Chinese herbs decoction, 0.8 1.2 parts of Herba Apii graveolentis extract, 79 parts of nut composite powder, 0.25 0.35 parts of xanthans, 0.08 0.12 parts of guar gum, 4.6 5.4 parts of Gluten, 0.18 0.22 parts of dietary alkali, 8 12 parts of millet powder, 46 parts of lotus nut starch, wheat flour are to 100 parts.The noodles are full of nutrition, rich in nutriments such as amino acid, vitamin and minerals, the antioxidant activity of body can not only be improved, strengthen immunity, it can also be to having certain health-care effect in terms of nerve center, it is able to maintain that neural ability of learning and memory, delays brain cell aging, to effectively prevent the generation of senile dementia disease.
Description
Technical field
The present invention relates to food processing technology fields, and in particular to a kind of lotus seeds nut health care noodles and its preparation side
Method.
Background technology
Alzheimer disease (Alzheimer disease, AD), is called senile dementia, be a kind of concealment of onset into
The nervous system degenerative disease of row sexual development is senile dementia the most common type type.Clinically with memory disorders, mistake
Language, appraxia, agnosia, the damage of visual space technical ability, execution dysfunction and the generalized dementias such as personality and behavior change are shown as
Feature is mainly shown as the neuropsychic symptoms such as gradual memory obstacle, cognition dysfunction, personality change and aphasis,
Seriously affect social, occupation and vital function.The cause of disease and pathogenesis of AD not yet illustrates, and characteristic pathology changes into β starch
Nerve fibril twines in the nerve cell that the extracellular senile plaque and Protein tau Hyperphosphorylationof that sample proteinosis is formed are formed
Knot and neuron loss are with glial cells hyperplasia etc..
China aged increasingly comes more at present, and the possibility with senile dementia is also increasing, and right at present
Mainly there are hypnotic, antipsychotic drug, antidepression, antiepileptic and Neuroprotective Agents etc. in the treatment of senile dementia,
Anti-acetylcholine amylase most outstanding, only has improvement to senile dementia, and have little effect, need to control for a long time
It treats, long-term drug therapy can not only make patient generate dependence to drug, it is also possible to damage the health of patient, and high
Expensive medical expenses also increase the financial burden of patient and its family.Dietary therapy and prevention are that one kind is safely and effectively treated
Method, being directed on the market, the noodles that the middle-aged and the old eats are less, Chinese patent《A kind of squid algal noodles and its preparation side
Method》(number of patent application:CN201210281198.6) disclose it is a kind of prepared as primary raw material using calamary minced fish and seaweed, tool
Nutritious health-care effect, suitable for the noodles that old child eats, Chinese patent《A kind of alimentary paste and preparation method thereof》(specially
Sharp application number:CN201410403325.4 one kind) is disclosed using needle mushroom as primary raw material, adds traditional Chinese medicine powder and other additives
The noodles of preparation, it is the senile dementia proposition improvement for the elderly to have good health-care effect, the above patent.
Invention content
To solve the above-mentioned problems, the present invention provides a kind of lotus seeds nut health care noodles and preparation method thereof, should
Noodles are full of nutrition, rich in nutriments such as amino acid, vitamin and minerals, can not only improve the antioxidant activity of body,
Strengthen immunity, additionally it is possible to having certain health-care effect in terms of nerve center, be able to maintain that neural learning and memory
Ability delays brain cell aging, to effectively prevent the generation of senile dementia disease.
The present invention is achieved through the following technical solutions:
A kind of lotus seeds nut health care noodles, are made of the raw material of following parts by weight:15-20 parts of Chinese herbs decoction, celery
0.8-1.2 parts of dish extract, 7-9 parts of nut composite powder, 0.25-0.35 parts of xanthans, 0.08-0.12 parts of guar gum, glutelin
4.6-5.4 parts of powder, 0.18-0.22 parts of dietary alkali, 8-12 parts of millet powder, 4-6 parts of lotus nut starch, wheat flour are to 100 parts.
Preferably, a kind of lotus seeds nut health care noodles, are made of the raw material of following parts by weight:Chinese herbs decoction 17.5
Part, 1 part of Herba Apii graveolentis extract, 8 parts of nut composite powder, 0.3 part of xanthans, 0.1 part of guar gum, 5 parts of Gluten, dietary alkali 0.2
Part, 10 parts of millet powder, 5 parts of lotus nut starch, wheat flour are to 100 parts.
Preferably, the preparation method of the Chinese herbs decoction is:The glutinous rehmannia of equivalent, fructus cannabis, Radix Polygalae crushed respectively
40 mesh sieve, and are uniformly mixed, and 10 times of amounts are added and decoct 3 times, each 2h, filtering merges 3 decocting liquids, with 0.2 μm of miillpore filter mistake
Filter, is concentrated into the 1/3 of former filtrate, obtains Chinese herbs decoction.
Preferably, the preparation method of the Herba Apii graveolentis extract is:Fresh celery is taken, leaf is taken, cleans rear drying and crushing extremely
80 mesh, by solid-liquid ratio 1:15 are added 81% ethanol solution, extract 3h at being 57 DEG C in temperature, are filtered after extraction, take filtrate,
It is dry, obtain Herba Apii graveolentis extract.
Preferably, the nut composite powder is made of the raw material of following parts by weight:1-2 parts of walnut, 3-4 parts of sesame,
6-8 parts of peanut;The preparation method of the nut composite powder is:Walnut, sesame, peanut are crushed respectively and sieved with 100 mesh sieve, by weight
It measures part to be uniformly mixed, obtains nut composite powder.
The present invention also provides a kind of preparation methods of lotus seeds nut health care noodles, include the following steps:
(1) auxiliary material pre-processes:Chinese herbs decoction is heated to 40-50 DEG C, Herba Apii graveolentis extract is added in Chinese herbs decoction, is filled
Divide and be stirred, obtains auxiliary material mixture;
(2) major ingredient pre-processes:Nut composite powder, xanthans, guar gum, Gluten, dietary alkali, millet powder, lotus nut starch
It is added in wheat flour, mixes well, obtain major ingredient mixture;
(3) knead dough:After mixing by the auxiliary material mixture obtained by step (1) and the major ingredient mixture obtained by step (2),
It is 35-45% that water to humidity, which is added, is placed in dough mixing machine and stirs 15-25min, obtains the small rice dough of lotus seeds;
(4) it cures:The small rice dough of lotus seeds obtained by step (3) is stood into 15-20min at room temperature, it is small lotus seeds must to be cured
Rice dough;
(5) tabletting, slitting:By the small rice dough of curing lotus seeds pressure rolling slabbing in noodle press obtained by step (4), thickness
For the smooth dough sheet of 1-1.2mm and surface, lotus seeds millet dough sheet is obtained;It is 2.5-3mm's that lotus seeds millet dough sheet, which is cut into thickness,
Noodles obtain the wet face slitting of lotus seeds millet;
(6) it is 5- to dry the wet face slitting of lotus seeds millet obtained by step (5) to noodles moisture at normal temperatures
6.5%, it is packed after cut-out, obtains finished product lotus seeds millet health care noodles.
Each main composition mechanism of action of the present invention is as follows:
For lotus seeds as dietotherapeutic resource, nutritive value is very high, contains abundant protein, fat, carbon hydrate
Object and trace element etc..German millet nutrition is comprehensive, abundant, and rich in vitamin B1, B2 etc., fat content is higher than rice, wheat etc.,
Protein quality is higher, it is necessary to which total amino acid content is above rice, wheat flour, corn.
Glutinous rehmannia can effectively control the activity of acetylcholinesterase, adjust the metabolism of neuropeptide, the development of neuron and god
The regeneration function of warp delays the aging and death of neuron, to keep the normal operation of central cholinergic system, inhibits and pre-
The generation of anti-senile dementia disease.
Contain abundant bioactive substance in fructus cannabis, there is wherein fructus cannabis oil the NO significantly reduced in brain tissue to contain
The horizontal function of amount and lipid metabolite MDA, can significantly improve the level of SOD, GSH-Px in brain tissue, and brain is inhibited to degenerate
Process, and by enhancing the oxidation resistance of body come anti-aging.
Radix Polygalae has multiple biological activities ingredient, can activate and enhance the function of UPP, promotes the identification of UPP approach and knot
The ability for closing abnormal agrin achievees the effect that remove intracerebral detrimental metabolic waste, protects the complete of neuronal structure and function
Whole property inhibits the generation of learning memory disorder, effectively prevents senile dementia to restore the vigor of nerve cell.
Contain abundant flavonoids bioactive substance in celery, wherein 4',5,7-trihydroxyflavone is most important flavonoids active matter
Matter, can improve learning ability and nerve correct response rate, significantly improve short term memory capacity, aspect resolving ability and
The holding capacity of memory has the remarkable result for improving senile dementia disease.
Sesame can synthesize and accumulate many secondary substances in human body biochemical metabolism, and the bioactivity of these substances is suitable
It is active, wherein lecithin not only rich content, and also emulsifiability is good, advantageously reduces hypertension, reduces cholesterol, enhancing
Blood vessel elasticity inhibits blood clotting, improves blood and supports, brain is promoted to support blood supply;These secondary substances can also participate in acetylcholine
Synthesis conversion, accelerate brain information conduction of velocity, enhance memory, there is remarkable result to the prevention of senile dementia disease.
Contain abundant glutamic acid in walnut, human body can be made to synthesize most important neurotransmitter gamma-amino fourth in brain tissue
Acid, it is the inhibitory neurotransmitter of central nervous system, can prevent to arrive at brain instruction maincenter with the relevant information of anxiety, from
And neuropsychiatric disease is treated, such as anxiety, neurasthenia, help cerebral nerve maincenter that can keep relaxation state, to nerve
System has calm and adjustment effect, and can improve cognition and movenent performance, improves learning and memory function, effectively plays benefit
The function of intelligence and enhancing memory.
Lysine in peanut can improve intelligence, and glutamic acid and asparatate can promote vigor and the increasing of nerve cell
The memory capability of powerful brain, the minerals such as zinc contained in peanut have the function of activating middle-aged and the old's brain cell, in addition, peanut
Liposoluble vitamin K, lecithin, the cephalin of middle rich content can delay cerebral function to fail;Youngster contained in peanut
Theine also has very strong anti-aging effects to human body.
The present invention has following advantageous effect:
Millet powder, lotus nut starch are added in wheat flour by the present invention, can solve cereal food by rational nutrition complement
The unbalanced problem of essential amino acid in product can more assign bread basket with millet, the special healthcare function of lotus seeds, keep noodles easy
In being absorbed by the body, promote digestion.
Glutinous rehmannia, fructus cannabis, Radix Polygalae are carried out the compound decocting liquid of compatibility making and are added in noodles by the present invention, can be refreshing from promoting
Through first activity, eliminates neural obstacle and improve nerve center oxidation resistance multiple target point, omnibearing protection neuron
Vigor, maintain neural ability of learning and memory, delay brain cell ageing process, prevent the generation of senile dementia disease.
The present invention will be added as nut composite powder in noodles after sesame, peanut, walnut compounding, and nutritional ingredient mutually recruits
It closes, can be provided for human body comprehensively and sufficient amino acid, vitamin and mineral, delaying human body aging and activation is helped to decline
Old brain cell and increase neural cell activity, effectively prevent the generation of senile dementia disease.
Specific implementation mode
In order to make the technical means, the creative features, the aims and the efficiencies achieved by the present invention be easy to understand, tie below
Specific embodiment is closed, the present invention is further explained.
Embodiment 1
A kind of lotus seeds nut health care noodles, are made of the raw material of following parts by weight:15 parts of Chinese herbs decoction, celery carry
Take 0.8 part of object, 7 parts of nut composite powder, 0.25 part of xanthans, 0.08 part of guar gum, 4.6 parts of Gluten, 0.18 part of dietary alkali,
8 parts of millet powder, 4 parts of lotus nut starch, 60.09 parts of wheat flour.
The preparation method of the Chinese herbs decoction is:The glutinous rehmannia of equivalent, fructus cannabis, Radix Polygalae be crushed into 40 mesh sieve respectively,
It is uniformly mixed, 10 times of amounts is added and decoct 3 times, each 2h, filtering merges 3 decocting liquids and is concentrated into 0.2 μm of filtering with microporous membrane
The 1/3 of former filtrate, obtains Chinese herbs decoction.
The preparation method of the Herba Apii graveolentis extract is:Fresh celery is taken, leaf is taken, drying and crushing is pressed to 80 mesh after cleaning
Solid-liquid ratio 1:15 are added 81% ethanol solution, extract 3h at being 57 DEG C in temperature, are filtered after extraction, take filtrate, dry, obtain
Herba Apii graveolentis extract.
The nut composite powder is made of the raw material of following parts by weight:1 part of walnut, 3 parts of sesame, 6 parts of peanut;It is described
The preparation method of nut composite powder be:Walnut, sesame, peanut are crushed respectively and sieved with 100 mesh sieve, is uniformly mixed by weight,
Obtain nut composite powder.
A kind of preparation method of above-mentioned lotus seeds nut health care noodles, includes the following steps:
(1) auxiliary material pre-processes:Chinese herbs decoction is heated to 45 DEG C, Herba Apii graveolentis extract is added in Chinese herbs decoction, fully
It is stirred, obtains auxiliary material mixture;
(2) major ingredient pre-processes:Nut composite powder, xanthans, guar gum, Gluten, dietary alkali, millet powder, lotus nut starch
It is added in wheat flour, mixes well, obtain major ingredient mixture;
(3) knead dough:After mixing by the auxiliary material mixture obtained by step (1) and the major ingredient mixture obtained by step (2),
It is 40% that water to humidity, which is added, is placed in dough mixing machine and stirs 20min, obtains the small rice dough of lotus seeds;
(4) it cures:The small rice dough of lotus seeds obtained by step (3) is stood into 17.5min at room temperature, lotus seeds millet must be cured
Dough;
(5) tabletting, slitting:By the small rice dough of curing lotus seeds pressure rolling slabbing in noodle press obtained by step (4), thickness
For the smooth dough sheet of 1.1mm and surface, lotus seeds millet dough sheet is obtained;By lotus seeds millet dough sheet slitting at the face that thickness is 2.75mm
Item obtains the wet face slitting of lotus seeds millet;
(6) it is 5.75% to dry the wet face slitting of lotus seeds millet obtained by step (5) to noodles moisture at normal temperatures,
It is packed after cut-out, obtains finished product lotus seeds millet health care noodles.
Embodiment 2
A kind of lotus seeds nut health care noodles, are made of the raw material of following parts by weight:17.5 parts of Chinese herbs decoction, celery
1 part of extract, 8 parts of nut composite powder, 0.3 part of xanthans, 0.1 part of guar gum, 5 parts of Gluten, 0.2 part of dietary alkali, millet
10 parts of powder, 5 parts of lotus nut starch, 52.9 parts of wheat flour.
The nut composite powder is made of the raw material of following parts by weight:1.5 parts of walnut, 3.5 parts of sesame, 7 parts of peanut;
The preparation method of the nut composite powder is:Walnut, sesame, peanut are crushed respectively and sieved with 100 mesh sieve, mixing by weight is equal
It is even, obtain nut composite powder.
Embodiment 3
A kind of lotus seeds nut health care noodles, are made of the raw material of following parts by weight:20 parts of Chinese herbs decoction, celery carry
Take 1.2 parts of object, 9 parts of nut composite powder, 0.35 part of xanthans, 0.12 part of guar gum, 5.4 parts of Gluten, 0.22 part of dietary alkali,
12 parts of millet powder, 6 parts of lotus nut starch, 45.71 parts of wheat flour.
The nut composite powder is made of the raw material of following parts by weight:2 parts of walnut, 4 parts of sesame, 8 parts of peanut;It is described
The preparation method of nut composite powder be:Walnut, sesame, peanut are crushed respectively and sieved with 100 mesh sieve, is uniformly mixed by weight,
Obtain nut composite powder.
Comparative example 1
Difference lies in without addition Chinese herbs decoction in composition of raw materials, specially with embodiment 1:1 part of Herba Apii graveolentis extract,
8 parts of nut composite powder, 0.3 part of xanthans, 0.1 part of guar gum, 5 parts of Gluten, 0.2 part of dietary alkali, 10 parts of millet powder, lotus seeds
5 parts of powder, 70.4 parts of wheat flour.
Comparative example 2
Difference lies in without addition Herba Apii graveolentis extract in composition of raw materials, specially with embodiment 1:Chinese herbs decoction 17.5
Part, 8 parts of nut composite powder, 0.3 part of xanthans, 0.1 part of guar gum, 5 parts of Gluten, 0.2 part of dietary alkali, 10 parts of millet powder,
5 parts of lotus nut starch, 53.9 parts of wheat flour.
Comparative example 3
Difference lies in without addition nut composite powder in composition of raw materials, specially with embodiment 1:Chinese herbs decoction 17.5
Part, 1 part of Herba Apii graveolentis extract, 0.3 part of xanthans, 0.1 part of guar gum, 5 parts of Gluten, 0.2 part of dietary alkali, 10 parts of millet powder,
5 parts of lotus nut starch, 61.9 parts of wheat flour.
Efficacy validation
Test example 1
It takes 12 monthly ages, the mouse of weight 30g or so 80, half male and half female to be randomly divided into 8 groups, takes one of which as empty
White control group, daily injecting normal saline, in addition the daily injection of d-galactose+sodium nitrite of 7 groups of mouse, continuous 2 months, is established
Model of Dementia group takes one group to be used as model group, is in addition used as experimental group for 6 groups, daily to be fed with embodiment 1-3 and comparative example 1-3 systems
At noodles, continuous feeding 4 weeks strictly operates, measurement cortex and hippocampus cholinesterase by cholinesterase (AchE) kit
Activity, the results are shown in Table 1:
1 each group mouse part brain area cholinesterase activity of table
Cholinergic defect and AD are closely related, and the cholinergic neuron at the positions such as AD intracerebrals septal area obviously subtracts
It is few, Ach as promote study and mediator, can illustrate the noodles of the invention prepared to choline by detecting the activity of AchE
It can the low improvement result of nervous function.As shown in Table 1, the cholinesterase activity of model group is apparently higher than blank control group, and
Embodiment 1-3 and comparative example 1-3 can reduce the cholinesterase activity of model group, and in contrast, embodiment 1-3 is to reducing choline
Esterase active has significant otherness, shows that lotus seeds nut health care noodles prepared by the present invention can be by inhibiting AchE's
Activity reduces the hydrolysis of Ach to achieve the effect that prevent AD.
Test example 2
It takes 12 monthly ages, the mouse of weight 30g or so 80, half male and half female to be randomly divided into 8 groups, takes one of which as empty
White control group, daily injecting normal saline, in addition the daily injection of d-galactose+sodium nitrite of 7 groups of mouse, continuous 2 months, is established
Model of Dementia group takes one group to be used as model group, is in addition used as experimental group for 6 groups, daily to be fed with embodiment 1-3 and comparative example 1-3 systems
At noodles, a mouse carries out water maze laboratory by continuous feeding 4 weeks, and it be more than 2s is successfully daily instruction to be stopped on safety board
Practice 2 times, totally 4 days, the time of safety board was escape latency, record mouse swimming track, result such as table 2 from fall asleep to reaching
It is shown:
2 each group Mice water maze experimental result of table
As shown in Table 2, model group is compared with blank control group, escapes latent time and has an extension of conspicuousness, platform across
The reduction of not in proper sequence or order number conspicuousness, and after feeding embodiment 1-3, the escape latent time of model mice and platform are obtained across number
The improvement of conspicuousness, though comparative example 1-3 has improvement to the escape latent time of model mice and platform across number, its effect
It is little, and it adds single component, nutrition is not comprehensive enough, effectively prevents the ineffective of AD.
After experiment, the neck that breaks puts to death mouse, detaches brain tissue, prepares single cell suspension, and lytic cell is exempted from according to putting
The content for illustrating operation detection A β of kit, the results are shown in Table 3:
3 each group Mice brain tissues A β expressions of table
Group | Aβ(ρg/ml) |
Blank control group | 1.01 |
Model group | 12.89 |
Embodiment 1 | 4.24 |
Embodiment 2 | 4.07 |
Embodiment 3 | 4.18 |
Comparative example 1 | 10.45 |
Comparative example 2 | 10.06 |
Comparative example 3 | 10.21 |
The aggregation of amyloid beta (A β) and neurofibrillary tangles are main pathological change and the senile plaques of AD
The aggregation of core component, A β can cause the raising of oxygen radical, inflammatory reaction, Apoptosis and Neuro-degenerative to become,
Therefore, it is to treat the effective ways of AD to inhibit the generation of A β.As can be seen from Table 3, the A β contents of model group are apparently higher than blank
Control group, and embodiment 1-3 can significantly reduce the A β contents of model group, illustrate lotus seeds nut health care face prepared by the present invention
Item can effectively treat AD.
In conclusion lotus seeds nut health care noodles prepared by the present invention can inhibit the activity of cholinesterase, A β are reduced
Content, so as to effectively treat and prevent AD.
Several embodiments of the invention above described embodiment only expresses, the description thereof is more specific and detailed, but simultaneously
Cannot the limitation to the scope of the claims of the present invention therefore be interpreted as.It should be pointed out that for those of ordinary skill in the art
For, without departing from the inventive concept of the premise, various modifications and improvements can be made, these belong to the guarantor of the present invention
Protect range.
Claims (6)
1. a kind of lotus seeds nut health care noodles, which is characterized in that be made of the raw material of following parts by weight:Chinese herbs decoction
15-20 parts, 0.8-1.2 parts of Herba Apii graveolentis extract, 7-9 parts of nut composite powder, 0.25-0.35 parts of xanthans, guar gum 0.08-
0.12 part, 4.6-5.4 parts of Gluten, 0.18-0.22 parts of dietary alkali, 8-12 parts of millet powder, 4-6 parts of lotus nut starch, wheat flour to 100
Part.
2. a kind of lotus seeds nut health care noodles as described in claim 1, which is characterized in that by the former material of following parts by weight
Material composition:17.5 parts of Chinese herbs decoction, 1 part of Herba Apii graveolentis extract, 8 parts of nut composite powder, 0.3 part of xanthans, 0.1 part of guar gum,
5 parts of Gluten, 0.2 part of dietary alkali, 10 parts of millet powder, 5 parts of lotus nut starch, wheat flour are to 100 parts.
3. a kind of lotus seeds nut health care noodles as claimed in claim 1 or 2, which is characterized in that the Chinese herbs decoction
Preparation method be:The glutinous rehmannia of equivalent, fructus cannabis, Radix Polygalae be crushed into 40 mesh sieve respectively, are uniformly mixed, 10 times of amounts are added and decoct
3 times, each 2h, filtering merges 3 decocting liquids and is concentrated into the 1/3 of former filtrate with 0.2 μm of filtering with microporous membrane, obtains Chinese medicine and decocts
Agent.
4. a kind of lotus seeds nut health care noodles as claimed in claim 1 or 2, which is characterized in that the celery extraction
The preparation method of object is:Fresh celery is taken, leaf is taken, drying and crushing is to 80 mesh after cleaning, by solid-liquid ratio 1:15 are added 81% ethyl alcohol
Solution extracts 3h at being 57 DEG C in temperature, is filtered after extraction, take filtrate, dry, obtains Herba Apii graveolentis extract.
5. a kind of lotus seeds nut health care noodles as claimed in claim 1 or 2, which is characterized in that the nut composite
Powder is made of the raw material of following parts by weight:1-2 parts of walnut, 3-4 parts of sesame, 6-8 parts of peanut;The system of the nut composite powder
Preparation Method is:Walnut, sesame, peanut are crushed respectively and sieved with 100 mesh sieve, is uniformly mixed by weight, obtains nut composite powder.
6. preparing a kind of lotus seeds nut health care noodles as described in any one in claim 1-5, which is characterized in that including with
Lower step:
(1) auxiliary material pre-processes:Chinese herbs decoction is heated to 40-50 DEG C, Herba Apii graveolentis extract is added in Chinese herbs decoction, is fully stirred
Mixing is mixed, auxiliary material mixture is obtained;
(2) major ingredient pre-processes:Nut composite powder, xanthans, guar gum, Gluten, dietary alkali, millet powder, lotus nut starch are added
It in wheat flour, mixes well, obtains major ingredient mixture;
(3) knead dough:After mixing by the auxiliary material mixture obtained by step (1) and the major ingredient mixture obtained by step (2), it is added
Water to humidity is 35-45%, is placed in dough mixing machine and stirs 15-25min, obtains the small rice dough of lotus seeds;
(4) it cures:The small rice dough of lotus seeds obtained by step (3) is stood into 15-20min at room temperature, the small rice and flour of lotus seeds must be cured
Group;
(5) tabletting, slitting:By the small rice dough of curing lotus seeds pressure rolling slabbing in noodle press obtained by step (4), thickness 1-
The smooth dough sheet of 1.2mm and surface, obtains lotus seeds millet dough sheet;Lotus seeds millet dough sheet is cut into the noodles that thickness is 2.5-3mm,
Obtain the wet face slitting of lotus seeds millet;
(6) it is 5-6.5% to dry the wet face slitting of lotus seeds millet obtained by step (5) to noodles moisture at normal temperatures, is cut
It has no progeny packaging, obtains finished product lotus seeds millet health care noodles.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810245261.8A CN108576623A (en) | 2018-03-23 | 2018-03-23 | A kind of lotus seeds nut health care noodles and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810245261.8A CN108576623A (en) | 2018-03-23 | 2018-03-23 | A kind of lotus seeds nut health care noodles and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108576623A true CN108576623A (en) | 2018-09-28 |
Family
ID=63627326
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810245261.8A Pending CN108576623A (en) | 2018-03-23 | 2018-03-23 | A kind of lotus seeds nut health care noodles and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108576623A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1709143A (en) * | 2005-06-25 | 2005-12-21 | 王浩贵 | Lotus seed health-care noodles |
CN104027428A (en) * | 2013-03-05 | 2014-09-10 | 刘燎原 | Preparation method of traditional Chinese medicine compound and application in prevention and treatment of Alzheimer disease |
CN106389740A (en) * | 2016-09-13 | 2017-02-15 | 王全峰 | Composition for preventing and/or delaying old people with mild cognitive impairment and use method thereof |
CN107212249A (en) * | 2017-04-25 | 2017-09-29 | 孙玉飞 | A kind of Noodles with Vegetables and preparation method thereof |
-
2018
- 2018-03-23 CN CN201810245261.8A patent/CN108576623A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1709143A (en) * | 2005-06-25 | 2005-12-21 | 王浩贵 | Lotus seed health-care noodles |
CN104027428A (en) * | 2013-03-05 | 2014-09-10 | 刘燎原 | Preparation method of traditional Chinese medicine compound and application in prevention and treatment of Alzheimer disease |
CN106389740A (en) * | 2016-09-13 | 2017-02-15 | 王全峰 | Composition for preventing and/or delaying old people with mild cognitive impairment and use method thereof |
CN107212249A (en) * | 2017-04-25 | 2017-09-29 | 孙玉飞 | A kind of Noodles with Vegetables and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
孙启发: "小米莲子面条中添加剂复配的研究", 《粮食加工》 * |
李杰,等: "基于响应面分析法的芹菜黄酮提取优化工艺研究", 《安徽农业科学》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Agarwal et al. | Alpha-amylase inhibition can treat diabetes mellitus | |
Soltani et al. | Evaluation of the effects of Cornus mas L. fruit extract on glycemic control and insulin level in type 2 diabetic adult patients: A randomized double-blind placebo-controlled clinical trial | |
US11166998B2 (en) | Eurycoma longifolia extract and its use in enhancing and/or stimulating immune system | |
CN112869162B (en) | Composition with functions of resisting fatigue and improving sleep and preparation method thereof | |
CN108785342B (en) | Moringa oleifera leaf extract with hypoglycemic activity and preparation method thereof | |
CN104312895B (en) | Fagopyrum tararicum vinegar and making method thereof | |
CN100521949C (en) | Antioxidant nutritious various-grain flour | |
Yang et al. | Anti-fatigue effect of aqueous extract of Hechong (Tylorrhynchus heterochaetus) via AMPK linked pathway | |
CN105249466B (en) | Hypoglycemic food composition | |
CN106819854A (en) | A kind of barley young leaf composite powder and preparation method thereof | |
CN106036898A (en) | Composition having anti-fatigue effects and preparation method and use thereof | |
JP4132635B2 (en) | Uninactivated enzyme-enhanced composition | |
JP2018519337A (en) | Method for producing fermented mineral raw pills having a function of improving constipation and fatigue recovery, and fermented mineral raw pills produced thereby | |
JP6735224B2 (en) | Activator of glucose metabolism in astrocytes | |
CN102771715B (en) | Preserved healthcare glutinous-rice-flour cake and method for preparing same | |
CN116762954A (en) | Health food for improving immunity and preparation method thereof | |
CN101647882A (en) | Haw monascus health product and preparation method thereof | |
JP6701583B2 (en) | Composition for treating type 1 diabetes mellitus | |
KR100697184B1 (en) | A functional food for a ginseng and mulberry and banaba and the producing method therof | |
CN116076710A (en) | Rose herbal ferment with anti-aging and whitening functions and preparation method and application thereof | |
CN108576623A (en) | A kind of lotus seeds nut health care noodles and preparation method thereof | |
CN109010579A (en) | A kind of antioxidant and anti-aging Chinese traditional compound medicine and preparation method thereof | |
CN108812916A (en) | A kind of hunchbacked milk tablet and its preparation with auxiliary hyperglycemic function | |
CN108660174A (en) | A kind of sesame biologically active peptide that is antifatigue, promoting proliferation of intestinal probiotics | |
CN108743840A (en) | A kind of Chinese medicine composition and preparation method thereof with auxiliary lipid-lowering function |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180928 |
|
WD01 | Invention patent application deemed withdrawn after publication |